BUBSX Performance — Baird Ultra Short Bond Fund, Investor Class
Data updated: 2026-08-14
BUBSX returned +1.70% year to date and +3.94% over one year to Jun 2026. Annualised returns are +4.94% over 3 years and +3.53% over 5 years. The fund trailed its Trading - Leveraged category average: $100 invested three years ago grew to $116, against $157 for the category, and to $104 over one year, against $121. Volatility over the past three years was 0.39% a year. In the 12 months to Jun 2026 the fund took in a net $470.8M, and assets reached $9.36B.
BUBSX Growth of $100
What $100 invested in Baird Ultra Short Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | BUBSX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $104 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $116 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $119 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $122 | $165 |
BUBSX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.70% |
| 1 year | +3.94% |
| 3 years (annualised) | +4.94% |
| 5 years (annualised) | +3.53% |
BUBSX Annual Returns
Calendar-year total returns of Baird Ultra Short Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +1.70% |
| 2025 | +4.54% |
| 2024 | +5.47% |
| 2023 | +5.43% |
| 2022 | +0.71% |
| 2021 | −0.06% |
| 2020 | +1.64% |
| 2019 (Jul–Dec) | +1.08% |
BUBSX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.3% | +0.3% | +0.2% | +0.3% | +0.3% | +0.3% | — | — | — | — | — | — |
| 2025 | +0.4% | +0.4% | +0.4% | +0.3% | +0.3% | +0.4% | +0.3% | +0.5% | +0.4% | +0.3% | +0.3% | +0.3% |
| 2024 | +0.5% | +0.3% | +0.5% | +0.3% | +0.5% | +0.4% | +0.6% | +0.6% | +0.5% | +0.3% | +0.4% | +0.3% |
| 2023 | +0.5% | +0.3% | +0.4% | +0.4% | +0.3% | +0.4% | +0.6% | +0.5% | +0.4% | +0.4% | +0.6% | +0.5% |
| 2022 | −0.1% | −0.2% | −0.2% | −0.1% | +0.1% | −0.1% | +0.2% | +0.1% | −0.1% | +0.2% | +0.4% | +0.4% |
| 2021 | 0.0% | +0.1% | 0.0% | 0.0% | 0.0% | −0.1% | 0.0% | 0.0% | 0.0% | −0.1% | 0.0% | −0.1% |
| 2020 | +0.2% | +0.3% | −1.0% | +0.9% | +0.7% | +0.3% | +0.2% | 0.0% | +0.1% | −0.1% | +0.1% | 0.0% |
| 2019 | — | — | — | — | — | — | +0.1% | +0.3% | +0.2% | +0.2% | +0.2% | +0.2% |
BUBSX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 0.39%
- Best month: +0.62% (Nov 2023)
- Worst month: +0.22% (Mar 2026)
BUBSX Fund Flows
Monthly money in and out of Baird Ultra Short Bond Fund, from SEC Form N-PORT.
- 12-month net flow: $470.8M
- 12-month gross sales (incl. reinvestments): $5.2B
- Sales ÷ redemptions: 1.10×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $345.3M | $413.8M | −$68.5M |
| May 2026 | $372.8M | $353.4M | $19.4M |
| Apr 2026 | $559.5M | $431.8M | $127.7M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $732.8M | $519.1M | $213.7M |
| Jan 2026 | $567.4M | $611.2M | −$43.7M |
| Dec 2025 | $599.9M | $450.5M | $149.4M |
| Nov 2025 | $357.4M | $709.8M | −$352.4M |
| Oct 2025 | $407.2M | $413.9M | −$6.7M |
| Sep 2025 | $493.7M | $326.7M | $167.0M |
| Aug 2025 | $362.7M | $237.8M | $124.8M |
| Jul 2025 | $381.4M | $241.2M | $140.1M |
BUBSX Assets Under Management
Net assets of Baird Ultra Short Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $9.36B |
| 2026-03-31 | $9.28B |
| 2025-12-31 | $9.29B |
| 2025-09-30 | $9.51B |
| 2025-06-30 | $9.07B |
| 2025-03-31 | $8.12B |
| 2024-12-31 | $7.70B |
| 2024-09-30 | $7.01B |
| 2024-06-30 | $6.64B |
| 2024-03-31 | $6.02B |
| 2023-12-31 | $6.23B |
| 2023-09-30 | $5.94B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.